Item 7.01. Regulation FD Disclosure.

On January 7, 2021, Viemed Healthcare, Inc. (the "Company") issued a press release announcing a recently completed non-invasive ventilation study led by Dr. William Frazier, Viemed's Chief Medical Officer, that evaluated clinical outcomes in chronic obstructive pulmonary disease patients with chronic respiratory failure treated with non-invasive ventilation at home. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the foregoing information, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information and Exhibit 99.1 be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits



   (d)   Exhibits



  Exhibit
  Number        Description


  99.1        Press Release dated     January     7    ,     202    1    .

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses